Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Supplements for Fatty Liver: Evidence-Based Approaches to Reducing Fatty Liver

Medically reviewed by 
 

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Peer Reviewed By
Updated On
July 15, 2024
published On
July 22, 2024
Supplements for Fatty Liver: Evidence-Based Approaches to Reducing Fatty Liver

Fatty liver disease, characterized by an accumulation of fat in liver cells, has become increasingly prevalent, impacting about 25 percent of adults in the U.S. Rising rates of fatty liver are being seen alongside increasing rates of related metabolic dysfunctions such as obesity and type 2 diabetes, primarily due to poor dietary habits and sedentary lifestyles. 

If untreated, fatty liver disease can progress to more severe conditions like non-alcoholic steatohepatitis (NASH) and cirrhosis with impaired liver function. While lifestyle changes remain the cornerstone of treatment, supplements have gained attention for their potential role in managing fatty liver. Here, we explore evidence-based approaches to reducing fatty liver with supplements to prevent complications and restore health. 

[signup]

What Is Fatty Liver Disease?

Fatty liver disease occurs when fat accumulates in liver cells, leading to liver enlargement and potential impairment of liver function. 

Non-Alcoholic Fatty Liver Disease (NAFLD)

NAFLD describes a spectrum of liver conditions in which liver cells become replaced by fat due to liver-damaging substances, viruses, or genetic disorders. This collection of conditions spans from fat accumulation in liver cells (simple steatosis) to non-alcoholic steatohepatitis (NASH), which involves liver inflammation that can progress to fibrosis and cirrhosis, which damage liver function

Most people with fatty liver disease have NAFLD, with around 25% of U.S. adults having NAFLD. Of those, about 20% have NASH (5% of adults in the U.S.).

NAFLD has more recently been classified as metabolic dysfunction-associated steatotic liver disease (MASLD) since it is closely associated with metabolic risk factors such as obesity, insulin resistance, type 2 diabetes, and dyslipidemia. It is considered the most common liver disorder globally, affecting individuals who do not consume excessive amounts of alcohol.

Alcoholic Fatty Liver Disease (AFLD)

Excessive alcohol consumption can lead to liver cells becoming replaced by fat, which may eventually progress to alcoholic steatohepatitis, fibrosis, and cirrhosis with impaired liver functioning. Although not all heavy drinkers develop AFLD, with factors such as genetics and nutritional status influencing its development, the severity of the disease correlates with the amount and duration of alcohol consumed. 

Common Causes and Risk Factors

Causes of NAFLD

Metabolic and lifestyle factors such as obesity, sedentary behavior, and poor dietary habits create metabolic dysfunction in the body, contributing to the development of NAFLD/MASLD

Insulin resistance impairs the ability of liver cells to properly regulate fat metabolism, leading to lipid accumulation. This dysregulation of insulin and blood sugar combined with other metabolic factors that characterize metabolic syndrome, such as obesity, hypertension, and dyslipidemia, collectively contribute to liver fat accumulation and inflammation.

Excess body weight, especially abdominal fat (visceral adiposity), is linked to insulin resistance and dyslipidemia, contributing to fat accumulation in liver cells. 

Diets high in conventionally raised saturated fats, trans fats, and refined carbohydrates can also worsen metabolic function, contributing to insulin resistance, inflammation, and oxidative stress, all of which play a role in the pathogenesis of fatty liver disease. 

These factors are worsened by lifestyle habits such as a lack of physical activity.

Risk factors for AFLD

The primary risk factor for AFLD is the chronic consumption of excessive amounts of alcohol, which disrupts liver function and metabolism, leading to the accumulation of fat within liver cells. 

Due to differences in alcohol metabolism, hormonal factors, and body composition, women are generally more susceptible to AFLD compared to men, even with lower levels of alcohol consumption. 

Genetic factors may also influence an individual's susceptibility to AFLD, with certain genetic variations predisposing to more severe liver damage in response to alcohol consumption. 

Alcohol interferes with the absorption and utilization of nutrients, resulting in deficiencies of essential nutrients such as folate and antioxidants that exacerbate liver damage in individuals with AFLD. 

Health Risks Associated with Fatty Liver

While this condition is often asymptomatic in its early stages, it can progress to more severe liver damage if left untreated. Potential complications of fatty liver disease include cirrhosis, liver failure, and an increased risk of heart disease.

Recognizing these causes and risk factors is essential for preventive measures, early detection, and targeted interventions to reduce the burden of both NAFLD and AFLD and avoid severe outcomes.

Supplements for Fatty Liver

Several supplements have garnered attention for their potential role in reducing fatty liver.  Clinical trials have demonstrated the efficacy of supplements such as milk thistle, omega-3 fatty acids, and vitamin E in reducing liver fat and inflammation in individuals with fatty liver disease. 

Common Supplements for Fatty Liver

Milk Thistle (Silymarin)

Milk thistle extract contains silymarin, a flavonoid with antioxidant and anti-inflammatory effects that is known for its liver-protective properties. Studies have shown that silymarin may help reduce liver inflammation and promote detoxification processes, potentially benefiting individuals with fatty liver disease.

A randomized double-blind study of 180 patients with confirmed diagnosis of NAFLD/NASH found that silymarin and vitamin E for 12 months resulted in the normalization of liver enzymes (transaminase), a significant reduction of gamma-glutamyl transferase levels, and the significant decrease of liver steatosis measured with ultrasound scan and liver biopsy with improvements in fasting glucose, insulin levels, and insulin resistance. 

Omega-3 Fatty Acids

Omega-3 fatty acids, found in fatty fish, walnuts, flax seeds, and fish oil supplements, have anti-inflammatory properties and help reduce liver fat accumulation in individuals with NAFLD. 

Vitamin E

Vitamin E is a potent antioxidant with the potential to reduce liver fat and inflammation in patients with NAFLD. Studies have shown promising results, although caution and individualized guidance are warranted due to the risk of adverse effects associated with high doses of vitamin E.

N-acetylcysteine (NAC)

NAC is a precursor to glutathione, a key antioxidant involved in liver detoxification processes. Studies suggest that NAC supplementation can support glutathione production and help alleviate oxidative stress in individuals with fatty liver disease.

Other Supplements

Other supplements, such as resveratrol and curcumin, have shown preliminary evidence of potential benefits for fatty liver disease. 

Risks and Considerations with Supplementation

While supplements offer potential benefits for fatty liver disease, supplementation should be used under the guidance of a knowledgeable professional. Some supplements may carry risks or side effects, particularly at high doses or in combination with other medications. For example, high doses of vitamin E may increase the risk of hemorrhagic stroke, while excessive intake of omega-3 fatty acids may lead to gastrointestinal discomfort or bleeding.

Individuals considering supplementation should seek guidance from healthcare professionals to ensure the individualization of a treatment plan for appropriate use and monitoring.

Lifestyle Approaches to Managing Fatty Liver

Dietary Changes

Following a balanced anti-inflammatory diet that limits processed sugars and carbohydrates and avoids inflammatory fats helps to reduce fat buildup in the liver. Emphasize foods such as fruits, vegetables, whole grains, and high-quality lean proteins to improve liver health by providing essential nutrients and reducing inflammation.

Exercise and Physical Activity

Regular moderate exercise incorporating aerobic exercise, such as brisk walking or cycling, and resistance training can be beneficial for maintaining a balanced weight, improving metabolic parameters, and reducing fatty liver disease. Aim for at least 30 minutes of moderate-intensity exercise on most days of the week.

Avoidance of Harmful Substances

Eliminating alcohol consumption and other harmful substances, such as tobacco and illicit drugs, can help protect liver health and support recovery from fatty liver disease. 

When Pharmaceutical Approaches Are Needed

When lifestyle changes and supplements alone are insufficient to manage fatty liver disease, pharmaceutical interventions may be necessary. This is particularly true when individuals have advanced stages of the disease or significant metabolic risk factors that require targeted treatment.

Common Medications

Pharmaceutical options for managing fatty liver disease typically target underlying risk factors such as insulin resistance, diabetes, and dyslipidemia to improve metabolic parameters, reduce liver inflammation, and slow the progression of liver damage.

Potential Side Effects and Risks

Medications used to treat insulin resistance or diabetes, such as metformin, may cause hypoglycemia or gastrointestinal symptoms, so regular monitoring of liver function and other metabolic parameters is important to ensure safety and efficacy.

When to Consult a Doctor

Signs You Should Seek Medical Advice

Medical advice may be necessary if symptoms indicating worsening fatty liver disease or other liver issues occur, such as abdominal pain, unexplained weight loss, fatigue, or jaundice. Immediate medical attention is necessary for severe abdominal pain, persistent vomiting, or signs of liver failure, such as confusion or bleeding.

Regular Monitoring and Follow-Up

Regular check-ups, typically every 6 to 12 months, are essential to monitor liver health and the effectiveness of treatments for fatty liver disease. 

Collaborating with Healthcare Professionals

A comprehensive multidisciplinary approach involving dietitians, doctors, hepatologists, and other specialists ensures optimal care for fatty liver disease. Collaboration with healthcare professionals allows for the development of personalized treatment plans to address underlying risk factors and avoid complications effectively.

[signup]

Key Takeaways

  • Fatty liver disease involves the accumulation of fat in liver cells and encompasses non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD).
  • Symptoms may be absent or include abdominal discomfort, fatigue, and jaundice. 
  • NAFLD is linked to metabolic changes, including insulin resistance, obesity, and metabolic syndrome.
  • AFLD results from excessive alcohol consumption.
  • Supplements like milk thistle, omega-3 fatty acids, vitamin E, and N-acetylcysteine show promise in reducing liver fat and inflammation.
  • A balanced approach integrating lifestyle changes, including an anti-inflammatory diet free of processed sugars and fats, exercise, supplements, and medical supervision, is crucial for managing fatty liver effectively.
  • Seeking medical advice for any concerns about fatty liver or liver health is encouraged to receive personalized guidance and appropriate interventions.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No items found.

Amato, M. C., & Giordano, C. (2014). Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction. International Journal of Endocrinology, 2014, 1–7. https://doi.org/10.1155/2014/730827

American Heart Association. (n.d.). Fatty liver disease may increase heart failure risk. Www.heart.org. https://www.heart.org/en/news/2022/11/16/fatty-liver-disease-may-increase-heart-failure-risk

American Liver Foundation. (n.d.). NASH Definition & Prevalence. American Liver Foundation. https://liverfoundation.org/liver-diseases/fatty-liver-disease/nonalcoholic-steatohepatitis-nash/nash-definition-prevalence/#:~:text=NAFLD%20is%20the%20most%20common

Baradeiya, A. M., Taghlabi, K. M., Saleh, A. N., Sindhura Manikonda, & Salim, S. S. (2023). Can Nutritional Supplements Benefit Patients With Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease? Curēus. https://doi.org/10.7759/cureus.40849

Bertagna, B. (2024, January 4). Understanding the Potential Benefits of Milk Thistle for Fatty Liver. Rupa Health. https://www.rupahealth.com/post/understanding-the-potential-benefits-of-milk-thistle-for-fatty-liver

Blake, K. (2023, May 22). Anti Inflammatory Diet 101: What to Eat and Avoid Plus Specialty Labs To Monitor Results. Rupa Health. https://www.rupahealth.com/post/anti-inflammatory-diet

Christie, J. (2023, January 6). A functional medicine approach to obesity and weight management. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-obesity

Cicero, A., Colletti, A., & Bellentani, S. (2018). Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence. Nutrients, 10(9), 1153. https://doi.org/10.3390/nu10091153

Cleveland Clinic. (2021, November 23). Liver Disease: Types. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17179-liver-disease

Cloyd, J. (2023a, April 10). A Functional Medicine Hypertension Protocol. Rupa Health. https://www.rupahealth.com/post/functional-medicine-hypertension-protocol

Cloyd, J. (2023b, July 5). The Role of the Liver and Gut in Detoxification and How to Support Them With Integrative Medicine. Rupa Health. https://www.rupahealth.com/post/the-role-of-the-liver-gut-in-detoxification-and-how-to-support-it-with-integrative-medicine

Cloyd, J. (2024, January 11). Integrating Resveratrol for Improved Insulin Sensitivity and Endocrine Health. Rupa Health. https://www.rupahealth.com/post/integrating-resveratrol-for-improved-insulin-sensitivity-and-endocrine-health

Cloyd, J. (2024b, January 22). Interpreting Liver Enzyme Tests: ALT, AST, and ALP in Liver Health Monitoring. Rupa Health. https://www.rupahealth.com/post/interpreting-liver-enzyme-tests-alt-ast-and-alp-in-liver-health-monitoring

Cloyd, K. (2023, December 19). How to interpret your lipid panel results. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-lipid-panel-results

Delli Bovi, A. P., Marciano, F., Mandato, C., Siano, M. A., Savoia, M., & Vajro, P. (2021). Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. Frontiers in Medicine, 8, 595371. https://doi.org/10.3389/fmed.2021.595371

DePorto, T. (2023, January 6). Omega 3’s: The Superfood Nutrient You Need To Know About. Rupa Health. https://www.rupahealth.com/post/omega-3s-the-superfood-nutrient-you-need-to-know-about

Diorio, B. (2023, January 17). Why Most Functional Medicine Practitioners Say No To Alcohol. Rupa Health. https://www.rupahealth.com/post/why-most-functional-medicine-practitioners-say-no-to-alcohol

Gillessen, A., & Schmidt, H. H.-J. . (2020). Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Advances in Therapy, 37(4), 1279–1301. https://doi.org/10.1007/s12325-020-01251-y

Izzo, C., Annunziata, M., Melara, G., Sciorio, R., Dallio, M., Masarone, M., Federico, A., & Persico, M. (2021). The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials. Nutrients, 13(3), 933. https://doi.org/10.3390/nu13030933

Karimi, G., Vahabzadeh, M., Lari, P., Rashedinia, M., & Moshiri, M. (2011). “Silymarin”, a Promising Pharmacological Agent for Treatment of Diseases. Iranian Journal of Basic Medical Sciences, 14(4), 308–317. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586829/

Keating, S. E., Sabag, A., Hallsworth, K., Hickman, I. J., Macdonald, G. A., Stine, J. G., George, J., & Johnson, N. A. (2023). Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia. Sports Medicine, 53(12), 2347–2371. https://doi.org/10.1007/s40279-023-01918-w

Khakham, C. (2023, March 7). Top Medical Evidence Supporting Curcumin’s Health Benefits. Rupa Health. https://www.rupahealth.com/post/top-medical-evidence-supporting-curcumins-health-benefits

Lieber, C. S. (2003). Relationships Between Nutrition, Alcohol Use, and Liver Disease. Alcohol Research & Health, 27(3), 220–231. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668875/

Maholy, N. (2023, March 9). Integrative Medicine Protocol For Reversing Type 2 Diabetes. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-protocol-for-reversing-type-2-diabetes

MedLine Plus. (2020, March 15). Metformin: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a696005.html

Meroni, M., Longo, M., Rametta, R., & Dongiovanni, P. (2018). Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. International Journal of Molecular Sciences, 19(12), 3857. https://doi.org/10.3390/ijms19123857

Mohammad Sadiq Jeeyavudeen, Shahanas KA Khan, Sherouk Fouda, & Pappachan, J. M. (2023). Management of metabolic-associated fatty liver disease: The diabetology perspective. World Journal of Gastroenterology, 29(1), 126–143. https://doi.org/10.3748/wjg.v29.i1.126

National Institute of Diabetes and Digestive and Kidney Diseases. (2019, November 27). Definition & Facts of NAFLD & NASH. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts

National Institute of Health. (2023, February 15). Office of Dietary Supplements - Omega-3 Fatty Acids. Nih.gov. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/

National Institutes of Health. (2021, March 26). Office of Dietary Supplements - Vitamin E. Nih.gov. https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/

Osna, N. A., Donohue, T. M., & Kharbanda, K. K. (2017). Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Research : Current Reviews, 38(2), 147–161. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513682/

Pais, R., Barritt, A. S., Calmus, Y., Scatton, O., Runge, T., Lebray, P., Poynard, T., Ratziu, V., & Conti, F. (2016). NAFLD and liver transplantation: Current burden and expected challenges. Journal of Hepatology, 65(6), 1245–1257. https://doi.org/10.1016/j.jhep.2016.07.033

Perumpail, B., Li, A., John, N., Sallam, S., Shah, N., Kwong, W., Cholankeril, G., Kim, D., & Ahmed, A. (2018). The Role of Vitamin E in the Treatment of NAFLD. Diseases, 6(4), 86. https://doi.org/10.3390/diseases6040086

Porayko, M. K., Articolo, A., Cerenzia, W., Coleman, B., Patel, D., & Stacy, S. (2022). Differences in NAFLD/NASH Management by Provider Specialty: Opportunities for Optimizing Multidisciplinary Care. Journal of Multidisciplinary Healthcare, Volume 15, 1533–1545. https://doi.org/10.2147/jmdh.s367607

Preston, J. (2022, November 10). What’s The Difference Between Good And Bad Dietary Fat? Rupa Health. https://www.rupahealth.com/post/dietary-fat-the-good-the-bad-and-the-misunderstood

Rinella, M. E., Lazarus, J. V., Vlad Ratziu, Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Juan Pablo Arab, Arrese, M., Bataller, R., Ulrich Beuers, Boursier, J., Elisabetta Bugianesi, Byrne, C., Castro, G. E., Chowdhury, A., Cortez-Pinto, H., & Cryer, D. (2023). A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, Publish Ahead of Print. https://doi.org/10.1097/hep.0000000000000520

Sato, K., Gosho, M., Yamamoto, T., Kobayashi, Y., Ishii, N., Ohashi, T., Nakade, Y., Ito, K., Fukuzawa, Y., & Yoneda, M. (2015). Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials. Nutrition, 31(7-8), 923–930. https://doi.org/10.1016/j.nut.2014.11.018

Spooner, M. H., & Jump, D. B. (2019). Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children. Current Opinion in Clinical Nutrition & Metabolic Care, 22(2), 103–110. https://doi.org/10.1097/mco.0000000000000539

Standford, J. (2024, March 19). Exploring the Link Between Insulin Resistance and Obesity. Rupa Health. https://www.rupahealth.com/post/insulin-resistance-obesity

Stanford, J. (2024, March 21). Insulin Resistance and Inflammation: Understanding the Connection. Rupa Health. https://www.rupahealth.com/post/insulin-resistance-and-inflammation-understanding-the-connection

Sweetnich, J. (2023a, April 13). What is NAC’s Role in The Body? Rupa Health. https://www.rupahealth.com/post/what-is-nacs-role-in-the-body

Sweetnich, J. (2023b, May 8). The Antioxidant Powerhouse: Exploring Testing, Health Benefits, and Sources of Vitamin E. Rupa Health. https://www.rupahealth.com/post/vitamin-e-101

Sweetnich, J. (2023c, May 8). Understanding the Importance of Folate Testing and Proper Supplementation for Optimal Health. Rupa Health. https://www.rupahealth.com/post/understanding-the-importance-of-folate-testing-and-proper-supplementation-for-optimal-health

Sweetnich, J. (2023d, May 19). Overview of The Liver 101: Top Conditions, Specialty Testing, and Integrative Medicine Treatment Options. Rupa Health. https://www.rupahealth.com/post/overview-liver-101-top-conditions-and-testing

Sweetnich, J. (2023e, June 30). Top 5 Antioxidants That Can Improve Your Health and How To Test Your Patient’s Levels. Rupa Health. https://www.rupahealth.com/post/top-5-antioxidants-to-improve-your-health

Tenório, M. C. dos S., Graciliano, N. G., Moura, F. A., Oliveira, A. C. M. de, & Goulart, M. O. F. (2021). N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants, 10(6), 967. https://doi.org/10.3390/antiox10060967

Vancells Lujan, P., Viñas Esmel, E., & Sacanella Meseguer, E. (2021). Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. Nutrients, 13(5), 1442. https://doi.org/10.3390/nu13051442

Weinberg, J. L. (2022, May 3). Tiredness, weight loss, and itching are signs of this dangerous liver disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-non-alcoholic-fatty-liver-disease

Weinberg, J. L. (2023a, January 11). How To Test Your Patients For Metabolic Syndrome. Rupa Health. https://www.rupahealth.com/post/how-to-test-your-patients-for-metabolic-syndrome-a-functional-medicie-approach

Weinberg, J. L. (2023b, June 1). If You’re Feeling Fatigued And Losing Weight Unexpectedly, Ask Your Practitioner For These 6 Lab Tests. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-non-alcoholic-fatty-liver-disease-nafld-protocol-testing-nutrition-and-supplements

Yoshimura, H. (2023a, October 16). An Integrative Approach to Liver Cirrhosis Management. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-liver-cirrhosis-management

Yoshimura, H. (2023b, October 19). What is Alcohol-Related Liver Disease and How Can Functional Medicine Help? Rupa Health. https://www.rupahealth.com/post/what-is-alcohol-related-liver-disease-and-how-can-functional-medicine-help

Yoshimura, H. (2023c, October 23). How to Support Your Liver Health With Nutritional Interventions in Functional Medicine. Rupa Health. https://www.rupahealth.com/post/nutritional-interventions-in-functional-medicine-for-liver-support

Yoshimura, H. (2023d, November 7). The remarkable power of exercise on our health: A comprehensive overview. Rupa Health. https://www.rupahealth.com/post/the-remarkable-power-of-exercise-on-our-health-a-comprehensive-overview

Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles